A Study of the Safety and Effectiveness of Canagliflozin (JNJ-28431754) in Promoting Weight Loss in Overweight and Obese Patients Who do Not Have Diabetes
Clinical trial NCT00650806 · COMPLETED
Trial details
- NCT number
- NCT00650806
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2008-09-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.